专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2010058423A9 NOVEL ANTIMICROBIALS 审中-公开
公开(公告)号：WO2010058423A9
公开(公告)日：2010-05-27
申请号：PCT/IN2009/000658
申请日：2009-11-18
申请人： PANACEA BIOTEC LTD. , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KANWAR, Sandeep , MAGADI, Sitaram, Kumar , SHARMA, Sudhir, Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KANWAR, Sandeep , MAGADI, Sitaram, Kumar , SHARMA, Sudhir, Kumar
IPC分类号： C07D413/10 , C07D413/14
摘要： The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula I or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant species of Staphylococcus, Streptococcus, Enterococcus, Bacterioides, Clostridia, H. influenza, Moraxella, acid-fast organisms such as Mycobacterium tuberculosis as well as Linezolid resistant species of Staphylococcus and Enterococcus.

2. 发明申请

WO2010150281A2 NOVEL AZABICYCLOHEXANES 审中-公开
标题翻译：新的雅各布
公开(公告)号：WO2010150281A2
公开(公告)日：2010-12-29
申请号：PCT/IN2010/000428
申请日：2010-06-22
申请人： PANACEA BIOTEC LTD. , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KAUR, Gurmeet , KANWAR, Sandeep , SINGH, Nishan , NANDA, Gurmeet Kaur , MAGADI, Sitaram Kumar , SHARMA, Sudhir Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KAUR, Gurmeet , KANWAR, Sandeep , SINGH, Nishan , NANDA, Gurmeet Kaur , MAGADI, Sitaram Kumar , SHARMA, Sudhir Kumar
IPC分类号： C07D221/22 , C07D401/10 , C07D413/10 , C07D413/14 , C07D417/10 , C07D471/04 , C07D491/08 , A61K31/46 , A61K31/496 , A61K31/498 , A61K31/5355 , A61K31/551 , C07D487/04 , A61P25/00 , A61P31/00
CPC分类号： C07D221/22 , C07D209/52 , C07D401/10 , C07D409/04 , C07D413/10 , C07D413/14 , C07D417/10 , C07D417/14 , C07D471/04 , C07D487/04 , C07D491/08
摘要： The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof.
摘要翻译：本发明涉及式（I）的新化合物，其药学上可接受的衍生物，互变异构体，立体异构体，包括R和S异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成式I的新化合物，其药学上可接受的衍生物，互变异构体形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。

3. 发明申请

WO2011070592A3 NOVEL SUGAR DERIVATIVES AS SGLT2 INHIBITORS 审中-公开
公开(公告)号：WO2011070592A3
公开(公告)日：2011-06-16
申请号：PCT/IN2010/000796
申请日：2010-12-09
申请人： PANACEA BIOTEC LTD. , JAIN, Rajesh , TREHAN, Sanjay , THUNGATHURTHI, Sastry V.R.S. , NANDA, Gurmeet, Kaur , DAS, Jagattaran , MAGADI, Sitaram, Kumar , SHARMA, Sudhir, Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , THUNGATHURTHI, Sastry V.R.S. , NANDA, Gurmeet, Kaur , DAS, Jagattaran , MAGADI, Sitaram, Kumar , SHARMA, Sudhir, Kumar
IPC分类号： C07H15/203 , C07D309/10
摘要： The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, analogs, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, analogs, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula I and methods of treating or preventing one or more conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGLT-2). The invention also relates to the use of compounds of Formula I, their pharmaceutically acceptable derivatives, analogs, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof, for the manufacture of a medicament for the prophylaxis, amelioration and/or treatment of conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGLT-2) and the related diseases, disorders and conditions, in a subject in need thereof.

4. 发明申请

WO2008090570A1 NOVEL ANTIMICROBIALS 审中-公开
标题翻译：新的抗生素
公开(公告)号：WO2008090570A1
公开(公告)日：2008-07-31
申请号：PCT/IN2008/000047
申请日：2008-01-24
申请人： PANACEA BIOTEC LTD , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KAUR, Gurmeet , KANWAR, Sandeep , MAGADI, Sitaram, Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KAUR, Gurmeet , KANWAR, Sandeep , MAGADI, Sitaram, Kumar
IPC分类号： C07F9/6584 , C07D413/10 , A61K31/495
CPC分类号： C07F9/6584
摘要： The present invention relates to novel phenyl oxazolidinone compounds of formula (I) or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula (I) or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant Staphylococcus spp., Streptococcus spp., Enterococcus spp., Bacterioides spp., Clostridia spp., H. influenza , Moraxella Spp., as well as acid-fast organisms such as Mycobacterium tuberculosis and the like.
摘要翻译：本发明涉及式（I）的新的苯基恶唑烷酮化合物或其药学上可接受的类似物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物。本发明还涉及合成式（I）的新型化合物或其药学上可接受的类似物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明还提供了包含新颖的式I化合物和使用它们的方法的药物组合物。本发明的化合物可用作抗微生物剂，对多种需氧和/或厌氧革兰氏阳性和/或革兰氏阴性病原体有效，如多药耐药葡萄球菌，链球菌属，肠球菌属，细菌属，，梭菌属（Clostridia spp。），流感嗜血杆菌（H. influenza），莫拉氏菌（Moraxella Spp。）以及耐酸生物如结核分枝杆菌等。

5. 发明申请

WO2009093269A9 NOVEL HETEROCYCLIC COMPOUNDS 审中-公开
公开(公告)号：WO2009093269A9
公开(公告)日：2009-07-30
申请号：PCT/IN2009/000061
申请日：2009-01-23
申请人： PANACEA BIOTEC LIMITED , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , SINGH, Nishan , NANDA, Gurmeet Kaur , MAGADI, Sitaram Kumar , SHARMA, Sudhir Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , SINGH, Nishan , NANDA, Gurmeet Kaur , MAGADI, Sitaram Kumar , SHARMA, Sudhir Kumar
IPC分类号： C07D243/14 , C07D403/06 , C07D413/12 , C07D487/04 , A61K31/551 , A61P3/10
摘要： The present invention relates to novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising compounds of Formula I and methods of treating or preventing one or more conditions that may be regulated or normalized via inhibition of dipeptidyl peptidase IV (DPP-IV). Formula I

6. 发明申请

WO2009116090A3 NOVEL ANTIMICROBIALS 审中-公开
公开(公告)号：WO2009116090A3
公开(公告)日：2009-09-24
申请号：PCT/IN2009/000184
申请日：2009-03-17
申请人： PANACEA BIOTEC LIMITED , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KANWAR, Sandeep , MAGADI, Sitaram, Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KANWAR, Sandeep , MAGADI, Sitaram, Kumar
IPC分类号： C07F9/6571 , C07F9/6509 , C07F9/6584 , C07F9/6558
摘要： The present invention relates to novel phenyl oxazolidinone compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula I and methods of treating or preventing conditions caused by microbial infections. The compounds of the present invention are effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant Staphylococcus spp., Streptococcus spp., Enterococcus spp., Bacterioides spp., Clostridia spp., H. influenza , Moraxella Spp., as well as acid-fast organisms such as Mycobacterium tuberculosis and the like.

7. 发明申请

WO2012172566A3 NOVEL SGLT INHIBITORS 审中-公开
公开(公告)号：WO2012172566A3
公开(公告)日：2012-12-20
申请号：PCT/IN2012/000416
申请日：2012-06-13
申请人： PANACEA BIOTEC LTD. , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , NANDA, Gurmeet Kaur , THUNGATHURTHI, Sastry, V.R.S. , SINGH, Nishan , SHARMA, Sudhir Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , NANDA, Gurmeet Kaur , THUNGATHURTHI, Sastry, V.R.S. , SINGH, Nishan , SHARMA, Sudhir Kumar
IPC分类号： A01N43/02 , A61K31/335
摘要： Novel compounds of Formula (I) are disclosed, their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prod rugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The disclosure also provides pharmaceutical compositions comprising novel compounds of Formula I and methods of treating or preventing one or more conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGL T-2).

8. 发明申请

WO2012042539A2 NOVEL BICYCLIC COMPOUNDS 审中-公开
标题翻译：新型双环化合物
公开(公告)号：WO2012042539A2
公开(公告)日：2012-04-05
申请号：PCT/IN2011/000669
申请日：2011-09-27
申请人： PANACEA BIOTEC LTD , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , SINGH, Nishan , SHARMA, Sudhir, Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , SINGH, Nishan , SHARMA, Sudhir, Kumar
CPC分类号： C07D209/52 , A61K31/403 , A61K45/06
摘要： The present invention relates to novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention further provides pharmaceutical compositions comprising compounds of Formula I and methods of treating or preventing one or more disorders of the central and/or peripheral nervous system, preferably by modulating neurological and/or psychiatric targets (GPCR and/or non-GPCR).
摘要翻译：本发明涉及式I的新化合物，其药学上可接受的衍生物，互变异构形式，异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成式I的新化合物，其药学上可接受的衍生物，互变异构形式，异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明还提供包含式I化合物的药物组合物和治疗或预防中枢和/或周围神经系统的一种或多种病症的方法，优选通过调节神经和/或精神病学靶标（GPCR和/或非GPCR）。

9. 发明申请

WO2013038429A2 NOVEL SGLT INHIBITORS 审中-公开
标题翻译：新型SGLT抑制剂
公开(公告)号：WO2013038429A2
公开(公告)日：2013-03-21
申请号：PCT/IN2012/000612
申请日：2012-09-12
申请人： PANACEA BIOTEC LTD. , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , NANDA, Gurmeet, Kaur , THUNGATHURTHI, Sastry, V., R., S. , SINGH, Nishan , SHARMA, Sudhir, Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , NANDA, Gurmeet, Kaur , THUNGATHURTHI, Sastry, V., R., S. , SINGH, Nishan , SHARMA, Sudhir, Kumar
IPC分类号： A61K31/70
CPC分类号： C07D309/10 , C07D493/08 , C07H7/04
摘要： The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula (I) and methods of treating or preventing one or more conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGLT-2).
摘要翻译：本发明涉及式（I）的新化合物，其药学上可接受的衍生物，互变异构形式，异构体，多晶型物，前药，代谢物，盐或溶剂合物。本发明还涉及合成式（I）的新化合物，其药学上可接受的衍生物，互变异构形式，异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明还提供包含式（I）的新型化合物和治疗或预防可通过抑制葡萄糖转运蛋白-2（SGLT-2）调节或归一化的一种或多种病症或疾病的药物组合物。

10. 发明申请

WO2009118765A2 NOVEL MONOAMINE RE-UPTAKE INHIBITOR 审中-公开
标题翻译：新型单体反应抑制剂
公开(公告)号：WO2009118765A2
公开(公告)日：2009-10-01
申请号：PCT/IN2009/000202
申请日：2009-03-27
申请人： PANACEA BIOTEC LIMITED , KESSAR, Satinder, Vir , KULKARNI, Shrinivas, Krishnarao , JAIN, Rajesh , TREHAN, Sanjay , MAGADI, Sitaram, Kumar , DAS, Jagattaran , KAUR, Gurmeet , SINGH, Kamal, Nain , LATA, Sneh , DHIR, Ashish
发明人： KESSAR, Satinder, Vir , KULKARNI, Shrinivas, Krishnarao , JAIN, Rajesh , TREHAN, Sanjay , MAGADI, Sitaram, Kumar , DAS, Jagattaran , KAUR, Gurmeet , SINGH, Kamal, Nain , LATA, Sneh , DHIR, Ashish
IPC分类号： C07D217/16 , C07D401/04 , C07D401/06 , C07D405/04 , C07D409/04 , C07D409/06 , C07D411/12 , C07D413/12
CPC分类号： C07D217/16 , C07D401/04 , C07D401/06 , C07D405/04 , C07D409/04 , C07D409/06 , C07D411/12 , C07D413/12
摘要： The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention further provides pharmaceutical compositions comprising compounds of Formula I and methods of treating or preventing one or more disorders of the central and/or peripheral nervous system that are responsive to inhibition of biogenic amines, in particular one or more, or any combination of serotonin, norepinephrine and dopamine.
摘要翻译：本发明涉及式（I）的新化合物，其药学上可接受的衍生物，互变异构体，立体异构体，包括R和S异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成式I的新化合物，其药学上可接受的衍生物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明进一步提供包含式I化合物的药物组合物和治疗或预防中枢和/或周围神经系统的一种或多种对生物胺抑制作用有反应的病症的方法，特别是一种或多种或任何组合 5-羟色胺，去甲肾上腺素和多巴胺。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式